Thursday, May 28 2026
2:45–3:45pm
CME/CE
Breaking the Cycle of Therapeutic Inertia: How Once-Weekly Insulins and Technology Can Transform Diabetes Care
Description
Insulin initiation and intensification can be challenging in primary care, yet timely action is critical for patients with type 2 diabetes mellitus (T2DM). Come away with practical strategies to overcome therapeutic inertia, review the role of basal insulin, and evaluate emerging once-weekly formulations to improve patient outcomes in T2DM care.
Learning Objectives
- Review the current role and benefits of basal insulin in T2DM management
- Identify barriers to insulin initiation and intensification as well as strategies to overcome these barriers
- Examine the evidence on emerging once-weekly insulins
Faculty
Education Partner
Supported by
- This activity is supported by an educational grant from Lilly